Comprehensive search ChatGPT Online Scientific research tools
Sign in Sign Up

Science hub Mutual Aid community


[Other] Type II & III inhibitors of tropomyosin receptor kinase (Trk): a 2020–2022 patent update

Ghihp Post time 6 day(s) ago | Show all posts |Read mode
Reward10points

journal：Expert Opinion on Therapeutic Patents

Authors：Petar Iliev; Carolin Jaworski; Carmen Wangler; Bjorn Wangler; Brent D. G. Page; Ralf Schirrmacher; Justin J. Bailey

Published date：--

DOI：10.1080/13543776.2024.2358818

PDF link：https://www.tandfonline.com/doi/pdf/10.1080/13543776.2024.2358818

Article link：http://dx.doi.org/10.1080/13543776.2024.2358818

Article Source：Informa UK Limited。


Remark：

Best Answer

Georgee Senior Member
6 day(s) ago
Please adopt

View Full Content

You can support us by donating, we would be very grateful.
Reply

Use magic Donate Report

All Reply1 Show all posts
Georgee Post time 6 day(s) ago | Show all posts

This post has been completed

Completed attachments will be deleted within 24 hours.
You can support us by donating, we would be very grateful.
Reply

Use magic Donate Report

Ghihp Lv.4
Senior Member

  • post

  • reply

  • points

    510

Same Category

Latest Reply

Announcement

Enthusiastic users today

Return to the list